Efeito do priming na redução da latência do pipecurônio, novo bloqueador neuromuscular não-despolarizante

Canga, José Carlos; Lehn, Carlos Neutzling; Tonelli, Deoclécio; Sacco, Paula de Camargo Neves; Beltrão, Danielle; Kirsch, Marcelo; Serralheiro, Fernando César; Cimerman, Gustavo.
Rev. bras. anestesiol ; 55(4): 381-386, jul.-ago. 2005. tab
Artigo Português, Inglês | LILACS | ID: lil-416899

Documentos relacionados

  1. Reversal of Deep Pipecuronium-Induced Neuromuscular Block With Moderate Versus Standard Dose of Sugammadex: A Randomized, Double-Blind, Noninferiority Trial.
  2. Pipecuronium revisited: dose-response and maintenance requirement in infants, children, and adults.
  3. [The efficacy and safety of priming principle with pipecuronium].
  4. [The characteristics of the action of nondepolarizing myorelaxants during operations on children with thermal injuries].
  5. Neuromuscular and cardiovascular effects of pipecuronium. A comparative study between different doses.
  6. [Features of anesthesia in surgical removal of insulinoma].
  7. [New russian myorelaxant vero-pipecuronium (pipecuronium bromide) used for the anesthetic management of operations on the thorax and abdomen organs].
  8. [Use of nondepolarizing myorelaxants in neonates].
  9. [CORRECTION OF INTRAABDOMINAL PRESSURE IN RATS IN AN ACUTE PANCREATITIS, USING INFUSION OF MYORELAXANT OF A DURABLE ACTION PIPECURONIUM BROMIDE].
  10. [The problem of airtightness during the use of a laryngeal mask under conditions of carboperitoneum and muscle relaxation].